Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Increased Alternative Macrophage-2 (M2) Polarization with Trib1 Gene over Expression in Myeloma Patients with Progressive Disease and Jak2 Inhibitors Reduce M2 Polarization

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Abigail Gillespie, BS, Cathy Wang, BS, Tiffany Lee, Suzie Vardanyan, MS, Jason Nosrati, BS, Jasmin Cao, Michael Zahab, Puja Mehta, BS, Gigi Garzio, George Tang, PhD, James R. Berenson, MD

Blood (2015) 126 (23): 1011.

https://doi.org/10.1182/blood.V126.23.1011.1011

Published: 2015

Journal Articles

SNP rs34172460 (S258A)Â in Gene CIP2A Correlates with Bortezomib Resistance in Multiple Myeloma Patients

George Tang, PhD, Mingjie Li, BS, Eric Sanchez, BA, Cathy Wang, BS, Suzie Vardanyan, BS, Tiffany Lee, Jason Nosrati, BS, Jasmin Cao, Michael Zahab, Puja Mehta, BS, Gigi Garzio, Haiming Chen, MD PhD, James Berenson, MD

Blood (2015) 126 (23): 5333.

https://doi.org/10.1182/blood.V126.23.5333.5333

Published: 2015

Journal Articles

Effects of Oprozomib in Combination with Pomalidomide and/or Dexamethasone on Human Multiple Myeloma Tumors Growing in SCID Mice

Eric Sanchez, BA, Mingjie Li, BS, Abigail Gillespie, BS, Puja Mehta, BS, Suzie Vardanyan, BS, Gigi Garzio, George Tang, PhD, Cathy Wang, BS, Haiming Chen, MD PhD, James R Berenson@imbcr.org, MD

Blood (2015) 126 (23): 5349.

https://doi.org/10.1182/blood.V126.23.5349.5349

Published: 2015

Journal Articles

Serum Levels of B-Cell Maturation Antigen Are Elevated in Waldenström's Macroglobulinemia Patients and Correlate with Disease Status and Conventional M-Protein and IgM Levels

Suzie Vardanyan, MS, Kirsten Meid, MPH, Kyle A Udd, BA, James Wang, MD, Mingjie Li, BS, Eric Sanchez, BA, Cathy Wang, BS, Abigail Gillespie, Maya Spitzer, Tanya M. Spektor, PhD, Anna Shvartsur, Nika Manik Harutyunyan, Gigi Garzio, George Tang, PhD, Haiming Chen, MD PhD, Steven P Treon, MD PhD, James Berenson, MD

Blood (2015) 126 (23): 1778.

https://doi.org/10.1182/blood.V126.23.1778.1778

Published: 2015

Journal Articles

Soluble Bcma in Myeloma Serum Binds Its Ligands BAFF and Prevents Normal Antibody Production in Multiple Myeloma Patients

Eric Sanchez, BA, Abigail Gillespie, BS, Nika Manik Harutyunyan, George Tang, PhD, Jillian Gottlieb, Suzie Vardanyan, MS, Mingjie Li, BS, Claudia Andreu-Vieyra, Michael Ghermezi, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Haiming Chen, MD PhD, James Berenson, MD

Blood (2015) 126 (23): 1799.

https://doi.org/10.1182/blood.V126.23.1799.1799

Published: 2015

Journal Articles

Crosslinking of Fc Gamma-Rllb and Fc Epsilon-RI Binding Peptides Inhibits Osteoclast Formation in Multiple Myeloma through Inactivation of the ITAM Signaling Pathway

Blood (2015) 126 (23): 2995.

https://doi.org/10.1182/blood.V126.23.2995.2995

Published: 2015

Journal Articles

Increased M2 Macrophages in Multiple Myeloma Patients with Progressive Disease and Down-Regulated Polarization with the JAK2 Inhibitor Ruxolitinib

Haiming Chen, MD, PhD, Eric Sanchez, BA, Mingjie Li, BS, Cathy Wang, BS, Abby Gillespie, BS, Anna Shvartsur, Suzie Vardanyan, MS, Nika M Harutyunyan, Gigi Garzio, George Tang, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2014) 124 (21): 4106.

https://doi.org/10.1182/blood.V124.21.4106.4106

Published: 2014

Journal Articles

Anti-Myeloma Activity by the Combination of the JAK2 Inhibitor Ruxolitinib with Lenalidomide and Corticosteroids

Blood (2014) 124 (21): 2114.

https://doi.org/10.1182/blood.V124.21.2114.2114

Published: 2014

Journal Articles

Circulating Bcma Binding to Its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients

Eric Sanchez, BA, Abigail Gillespie, Nika M Harutyunyan, George Tang, PhD, Jillian Gottlieb, Suzie Vardanyan, MS, Mingjie Li, BS, Claudia Andreu-Vieyra, Michael Ghermezi, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Judith Finlay, PhD, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2014) 124 (21): 4713.

https://doi.org/10.1182/blood.V124.21.4713.4713

Published: 2014

Journal Articles

Carfilzomib Overcomes Resistance to Bortezomib in the Human Lagk-1A Multiple Myeloma Xenograft Model

Eric Sanchez, BA, Mingjie Li, BS, Abigail Gillespie, Nika M Harutyunyan, Gigi Garzio, Joseph Ben-Zvi, Jillian Gottlieb, George Tang, PhD, Cathy Wang, BS, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2014) 124 (21): 5720.

https://doi.org/10.1182/blood.V124.21.5720.5720

Published: 2014

Journal Articles

Levels of Uninvolved Immunoglobulin Predict Clinical Status and Progression-Free Survival for Multiple Myeloma Patients

Nika M Harutyunyan, Suzie Vardanyan, MS, Michael Ghermezi, Jillian Gottlieb, Ariana Berenson, Claudia Andreu-Vieyra, George Tang, PhD, Eric Sanchez, BA, Mingjie Li, BS, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Haiming Chen, MD, PhD, Judith Finlay, PhD, James R Berenson, MD

Blood (2014) 124 (21): 2125.

https://doi.org/10.1182/blood.V124.21.2125.2125

Published: 2014

Journal Articles

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Cathy Wang, Kevin Delijani, Ran Halleluyan, Joseph Ben-Zvi, Mitchell Song, Eric Sanchez, Benjamin Bonavida, Ph.D, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2013) 122 (21): 5362.

https://doi.org/10.1182/blood.V122.21.5362.5362

Published: 2013

Journal Articles

Increased M2 Macrophages and Higher Levels Of The Tribble Family Member Trib1 In Monocytes Are Associated With Progressive Disease In Multiple Myeloma (MM) Patients

Haiming Chen, MD., Ph.D, Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Cathy Wang, Kevin Delijani, Joseph Ben-Zvi, Mitchell Song, Ran Halleluyan, Eric Sanchez, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2013) 122 (21): 3127.

https://doi.org/10.1182/blood.V122.21.3127.3127

Published: 2013

Journal Articles

Anti-Myeloma Effects of Carfilzomib with Cyclophosphamide (CY) or Bendamustine (Ben).

Eric Sanchez, Mingjie Li, Cathy Wang, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 2952.

https://doi.org/10.1182/blood.V120.21.2952.2952

Published: 2012

Journal Articles

Phosphoinositide 3'-Kinase (PI3K) Delta Inhibitor, GS-9820, Enhances Anti-Tumor Efficacy When Combined with Conventional Chemotherapeutic Agents in Primary Samples and Human Tumor Xenograft Model of Multiple Myeloma

Eric Sanchez, Mingjie Li, Cathy Wang, Haiming Chen, MD., Ph.D, Dave M. Johnson, Brian J. Lannutti, PhD, James R. Berenson, MD

Blood (2012) 120 (21): 4017.

https://doi.org/10.1182/blood.V120.21.4017.4017

Published: 2012

Journal Articles

Blockage of CGEN-928 Expression Down-Regulates AKT Signaling Pathway and Inhibits Multiple Myeloma (MM) Cell Proliferation

Haiming Chen, Mingjie Li, Jennifer Li, Marissa P Dreyer, Cameryn P Ahles, Tiffany Lee, Joleen T Qiu, Cathy Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, Ofer Levy, Liat Dassa, Gady Cojocaru, Zurit Levine, James R. Berenson, MD

Blood (2011) 118 (21): 5102.

https://doi.org/10.1182/blood.V118.21.5102.5102

Published: 2011

Journal Articles

Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206

Eric Sanchez, Cydney M Nichols, Alison C Lam, Mingjie Li, Cathy Wang, Colsen A Beveridge, Jacob T Lista, Andrew Leu, Kevin Delijani, Haiming Chen, James R. Berenson, MD

Blood (2011) 118 (21): 5107.

https://doi.org/10.1182/blood.V118.21.5107.5107

Published: 2011

Journal Articles

Efficacy and Tolerability of CEP-18770 in Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM)

Eric Sanchez, Cydney M Nichols, Alison C Lam, Mingjie Li, Jennifer Li, Cathy Wang, Colsen A Beveridge, Jacob T Lista, Haiming Chen, James R. Berenson, MD

Blood (2011) 118 (21): 2946.

https://doi.org/10.1182/blood.V118.21.2946.2946

Published: 2011

Journal Articles

Frequent Dysregulation of Fc Gamma Receptor IIb (Fc γRIIb) and Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling Occurs in Multiple Myeloma (MM) Patients

Jennifer Li, Andrew Leu, Mingjie Li, Ethan D Hobel, Kevin Delijani, Joleen T Qiu, David Ramirez, Alison C Lam, Cathy Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, Haiming Chen, James R. Berenson, MD

Blood (2011) 118 (21): 2917.

https://doi.org/10.1182/blood.V118.21.2917.2917

Published: 2011

Journal Articles

Using SCID-Hu Models to Evaluate the Sequencing of Bortezomib Therapy for Multiple Myeloma (MM)

Eric Sanchez, PhD, Mingjie Li, PhD, Cathy Wang, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, Jacqueline Hilger, MS, Barbara Hibner, PhD, James R. Berenson, MD

Blood (2010) 116 (21): 5012.

https://doi.org/10.1182/blood.V116.21.5012.5012

Published: 2010

NARROW

Increased Alternative Macrophage-2 (M2) Polarization with Trib1 Gene over Expression in Myeloma Patients with Progressive Disease and Jak2 Inhibitors Reduce M2 Polarization

SNP rs34172460 (S258A)Â in Gene CIP2A Correlates with Bortezomib Resistance in Multiple Myeloma Patients

Effects of Oprozomib in Combination with Pomalidomide and/or Dexamethasone on Human Multiple Myeloma Tumors Growing in SCID Mice

Serum Levels of B-Cell Maturation Antigen Are Elevated in Waldenström's Macroglobulinemia Patients and Correlate with Disease Status and Conventional M-Protein and IgM Levels

Soluble Bcma in Myeloma Serum Binds Its Ligands BAFF and Prevents Normal Antibody Production in Multiple Myeloma Patients

Crosslinking of Fc Gamma-Rllb and Fc Epsilon-RI Binding Peptides Inhibits Osteoclast Formation in Multiple Myeloma through Inactivation of the ITAM Signaling Pathway

Increased M2 Macrophages in Multiple Myeloma Patients with Progressive Disease and Down-Regulated Polarization with the JAK2 Inhibitor Ruxolitinib

Anti-Myeloma Activity by the Combination of the JAK2 Inhibitor Ruxolitinib with Lenalidomide and Corticosteroids

Circulating Bcma Binding to Its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients

Carfilzomib Overcomes Resistance to Bortezomib in the Human Lagk-1A Multiple Myeloma Xenograft Model

Levels of Uninvolved Immunoglobulin Predict Clinical Status and Progression-Free Survival for Multiple Myeloma Patients

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Increased M2 Macrophages and Higher Levels Of The Tribble Family Member Trib1 In Monocytes Are Associated With Progressive Disease In Multiple Myeloma (MM) Patients

Anti-Myeloma Effects of Carfilzomib with Cyclophosphamide (CY) or Bendamustine (Ben).

Phosphoinositide 3'-Kinase (PI3K) Delta Inhibitor, GS-9820, Enhances Anti-Tumor Efficacy When Combined with Conventional Chemotherapeutic Agents in Primary Samples and Human Tumor Xenograft Model of Multiple Myeloma

Blockage of CGEN-928 Expression Down-Regulates AKT Signaling Pathway and Inhibits Multiple Myeloma (MM) Cell Proliferation

Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206

Efficacy and Tolerability of CEP-18770 in Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM)

Frequent Dysregulation of Fc Gamma Receptor IIb (Fc γRIIb) and Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling Occurs in Multiple Myeloma (MM) Patients

Using SCID-Hu Models to Evaluate the Sequencing of Bortezomib Therapy for Multiple Myeloma (MM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only